Antiviral Medicines Assessment- What Is Driving High Clinical Added Value In France?
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.3062
https://www.valueinhealthjournal.com/article/S1098-3015(17)33397-1/fulltext
Title :
Antiviral Medicines Assessment- What Is Driving High Clinical Added Value In France?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)33397-1&doi=10.1016/j.jval.2017.08.3062
First page :
A791
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2145